Aetna Inc (AET) Given Consensus Recommendation of “Buy” by Analysts

Shares of Aetna Inc (NYSE:AET) have been assigned an average recommendation of “Buy” from the twenty-four ratings firms that are presently covering the firm, MarketBeat reports. Ten equities research analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $186.69.

A number of research analysts recently issued reports on the company. Cantor Fitzgerald reiterated a “neutral” rating and set a $175.00 price objective on shares of Aetna in a research note on Monday, October 23rd. Citigroup boosted their price objective on Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research note on Thursday, November 2nd. BMO Capital Markets boosted their price objective on Aetna from $175.00 to $200.00 and gave the company a “market perform” rating in a research note on Friday, October 27th. Deutsche Bank upgraded Aetna from a “hold” rating to a “buy” rating and upped their price target for the stock from $195.00 to $212.00 in a research note on Monday, January 22nd. Finally, Piper Jaffray Companies restated a “hold” rating and issued a $187.00 price target on shares of Aetna in a research note on Friday, November 3rd.

Aetna (NYSE AET) opened at $176.39 on Friday. The stock has a market capitalization of $57,520.00, a P/E ratio of 30.68, a P/E/G ratio of 1.47 and a beta of 0.60. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.53 and a current ratio of 1.68. Aetna has a 52 week low of $120.39 and a 52 week high of $194.40.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, January 30th. The company reported $1.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.18 by $0.07. The company had revenue of $14.74 billion during the quarter, compared to the consensus estimate of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The firm’s revenue was down 6.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.08 EPS. research analysts predict that Aetna will post 10.99 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, January 26th. Shareholders of record on Thursday, January 11th were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, January 10th. This represents a $2.00 annualized dividend and a yield of 1.13%. Aetna’s payout ratio is 34.78%.

Several institutional investors and hedge funds have recently modified their holdings of the company. Janus Henderson Group PLC raised its holdings in shares of Aetna by 1.8% during the 3rd quarter. Janus Henderson Group PLC now owns 4,407,172 shares of the company’s stock worth $700,784,000 after acquiring an additional 78,272 shares in the last quarter. Neuberger Berman Group LLC raised its holdings in shares of Aetna by 5.9% during the 3rd quarter. Neuberger Berman Group LLC now owns 1,487,570 shares of the company’s stock worth $236,538,000 after acquiring an additional 82,540 shares in the last quarter. Orbimed Advisors LLC raised its holdings in shares of Aetna by 57.3% during the 3rd quarter. Orbimed Advisors LLC now owns 1,396,500 shares of the company’s stock worth $222,057,000 after acquiring an additional 508,600 shares in the last quarter. Wells Fargo & Company MN raised its holdings in shares of Aetna by 1.9% during the 4th quarter. Wells Fargo & Company MN now owns 1,391,889 shares of the company’s stock worth $251,083,000 after acquiring an additional 26,293 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. raised its holdings in shares of Aetna by 2.6% during the 4th quarter. Schwab Charles Investment Management Inc. now owns 1,235,475 shares of the company’s stock worth $222,868,000 after acquiring an additional 30,799 shares in the last quarter. 87.41% of the stock is currently owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY NOTICE: This article was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another site, it was illegally copied and republished in violation of U.S. & international copyright and trademark legislation. The correct version of this article can be viewed at https://www.americanbankingnews.com/2018/02/10/aetna-inc-aet-given-consensus-recommendation-of-buy-by-analysts.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply